- Previous Close
39.27 - Open
39.27 - Bid 38.32 x --
- Ask 38.38 x --
- Day's Range
37.93 - 39.28 - 52 Week Range
22.85 - 40.48 - Volume
651,870 - Avg. Volume
898,714 - Market Cap (intraday)
4.094B - Beta (5Y Monthly) 0.48
- PE Ratio (TTM)
38.77 - EPS (TTM)
0.99 - Earnings Date --
- Forward Dividend & Yield 1.30 (3.39%)
- Ex-Dividend Date Jan 10, 2025
- 1y Target Est
--
Hangzhou Biotest Biotech Co.,Ltd. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and instruments in China and internationally. The company offers medical test products for fertility health, cardiology, oncology, inflammation, biochemistry, and various infectious diseases. It also provides veterinary test kits; fluorescence immunoassay rapid test kits; and other rapid testing kits. The company was founded in 2008 and is based in Hangzhou, China.
www.biotests.com.cnRecent News: 688767.SS
View MorePerformance Overview: 688767.SS
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688767.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688767.SS
View MoreValuation Measures
Market Cap
4.09B
Enterprise Value
2.48B
Trailing P/E
38.77
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.81
Price/Book (mrq)
1.72
Enterprise Value/Revenue
4.79
Enterprise Value/EBITDA
22.19
Financial Highlights
Profitability and Income Statement
Profit Margin
31.52%
Return on Assets (ttm)
--
Return on Equity (ttm)
7.36%
Revenue (ttm)
560.59M
Net Income Avi to Common (ttm)
176.68M
Diluted EPS (ttm)
0.99
Balance Sheet and Cash Flow
Total Cash (mrq)
1.61B
Total Debt/Equity (mrq)
0.03%
Levered Free Cash Flow (ttm)
--